Regulating vaccines under the same liability regime as all other pharmaceuticals, and acknowledging problems as well as benefits associated with them, will likely lead to safer vaccines and a better informed public.
Why are America’s Tier 1A workers the most likely to refuse vaccination? Gallup, and numerous other surveys and reports, produce unexpected results.
It would be foolhardy to base public policy decisions on the unrealistic prospect of a quick-fix vaccine.
The politicization of research funding is pervasive and paramount in decision-making.
Governments have vast financial interests that skew their medical research.
A documentary on the mother of all medical controversies.
Mumps outbreaks occur continually, most of them small and unreported. They’re attracting attention today only because NHL players are involved. And they’re certain to attract attention in future.
Rolling back the government advantages given vaccines would level the R&D playing field and help end the drought in pharmaceutical breakthroughs.
Mistakes in novel areas of science inevitably happen, and especially in highly politicized periods where public panic can run high and governments are under the gun.
The medical-industrial-governmental complex spends more and more but has less and less to show for it.